BADGER, Shot, 149

BAKER, Shot, 17, 78

BANEBERRY, Shot, 356–357

Barss report, 80, 82–85, 116–118, 160, 164–165

Basal cell carcinomas, 63, 362

Basal cells, 81, 362

Battalion Combat Teams (BCTs), 113–114, 139

Bechtel Nevada, 309, 317, 323

Becquerel (Bq), 362

BEIR V. See Biological Effects of Ionizing Radiation

Benefit of the doubt

denied to atomic veterans, 128, 137, 140, 143–145

given to atomic veterans, 3, 25, 38–40

importance of, 39–40, 230, 265

Beta particles, 32, 34, 363

skin and eye doses from exposure to, 3, 66, 80–81

Beta radiation, 21, 54, 63, 80, 140, 363

adjusting, 82

Beta skin and eye dose estimates, 160–166

Beta-to-gamma dose ratios, 81–84, 116–117, 363

for contaminated surfaces used at Pacific tests, 83

Bias, 68, 363

correction of, 72

See also Accuracy;

Precision

Bias factors, 315, 363

introduced into film-badge data reporting, 72

Bikini Atoll, nuclear testing in, 17, 73, 78, 218, 283

Bile duct cancer, 24

Bingham, New Mexico, 17

Bioassay program to assess internal exposures to plutonium, 247–248

Biokinetic model, 101, 170, 187, 363

Biological effectiveness, 363

of alpha particles, 105, 185

of neutrons, 159

Biological Effects of Ionizing Radiation (BEIR V), 165

Biological responses, 105, 363

“Black rain,” 107

Blast-wave effects, 21

analysis of potential inhalation doses due to, 335–348

discussion of dose reconstructions for participant groups, 345–347

discussion of example analysis and

importance of inhalation doses, 342–344

effects of neglected, 3, 204–205

implications for dose reconstructions for atomic veterans, 335–348

implications of, 344–345

at Operation PLUMBBOB, Shot HOOD, 339–342

radiation environment in forward areas at Shot HOOD, 335–338

Boarding parties, 73, 78

BOLTZMANN, Shot, 201

Bone cancer, 25, 178

Bq. See Becquerel

Brain cancer, 25

BRAVO, Shot, 106–107, 184, 218, 283–285, 328

Breast cancer, 24

BRER. See Board on Radiation Effects Research

Bronchiolo-alveolar cancer, 25

Burden of proof, 66

Bushey, Frank, 165

BUSTER-JANGLE, Operation, 17, 139, 194, 196

C

C. See Coulomb

C and P. See Compensation and Pension Service

Calculations, problem with illegible, 4

Calibration errors, 71, 363

Camp Desert Rock (CDR), 22, 137

Camp Mercury, 136

Cancers, 177–179, 255, 363

listed as radiogenic, 24–25, 363

Case #22, 125, 128, 144, 180, 212, 282–285

dose summary report, 282

external dose assessment, 284

internal dose assessment, 285

total dose summary, 285

unit and personal activities, 283

Case #60, 212, 234, 238, 286–290

dose summary report, 286

external dose assessment, 288

internal dose assessment, 289

total dose summary, 285

unit and personal activities, 287

Front Matter (R1-R16)

Public Summary (1-4)

Executive Summary (5-14)

I. Introduction (15-43)

II. The Committee's Process (44-50)

III. The Process of Submitting and Deciding Claims (51-64)

IV. Process of Dose Reconstruction in NTPR Program (65-123)

V. Committee's Findings Related to NTPR Dose Reconstruction Program (124-230)

VI. Findings Related to Other Issues (231-256)

VII. Conclusions (257-264)

VIII. Recommendations (265-266)

References (267-278)

Appendix A: Examples of Dose Reconstruction Memoranda From Sample Cases Reviewed by Committee (279-290)

Appendix B: Sampled Case Files of Dose Reconstructions Reviewed by Committee (291-301)

Appendix C: Names of Invited Speakers and Interactions with Veterans (302-304)

Appendix D: Responses to Committee's Questions (305-334)

Appendix E: Analysis of Potential Inhalation Doses Due to Blast-Wave Effects at Operation PLUMBBOB, Shot HOOD, and Implications for Dose Reconstructions for Atomic Veterans (335-348)

Appendix F: Unit Dose Reconstruction for Task Force Warrior at Operation PLUMBBOB, Shot SMOKY (349-360)

Glossary (361-378)

List of Abbreviations (379-380)

Committee Biographies (381-384)

Index (385-399)